** Shares of telehealth firm Doximity DOCS.N slump 14.7% to $49.84 after co's forecast misses expectations
** Co forecasts FY26 revenue between $619 mln and $631 mln vs analysts' estimate of $635 mln - data compiled by LSEG
** Midpoint of Q1 revenue outlook also below estimate
** At least four brokerages cut PT, including Truist Securities
** Piper Sandler lowers PT but says they "would buy this morning's weakness" as co's top-line growth forecast is appropriate due to uncertain impact of policy
** Eight out of 20 analysts rate stock as "buy" or higher, 12 "hold"; median PT is $70
** Including session's moves, DOCS down 5.6% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.